Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock.
about
Lipopolysaccharide-binding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranesDual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cellsConventional, molecular methods and biomarkers molecules in detection of septicemiaExpansion of the Bactericidal/Permeability Increasing-like (BPI-like) protein locus in cattleLipopolysaccharide and its analog antagonists display differential serum factor dependencies for induction of cytokine genes in murine macrophages.Role of plasma, lipopolysaccharide-binding protein, and CD14 in response of mouse peritoneal exudate macrophages to endotoxinFluorescence resonance energy transfer analysis of lipopolysaccharide in detergent micellesEffect of plasma phospholipid transfer protein deficiency on lethal endotoxemia in mice.Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5.Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Effect of anticoagulants on binding and neutralization of lipopolysaccharide by the peptide immunoglobulin conjugate CAP18(106-138)-immunoglobulin G in whole bloodMode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice.Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha.Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact.Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4.LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.Alcoholic liver disease and the gut-liver axis.Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule.The role of lipopolysaccharide-binding protein in innate immunity: a revisit and its relevance to oral/periodontal health.The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins.Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood.Immunoreactivity and bioactivity of lipopolysaccharide-binding protein in normal and heat-inactivated sera.Activation of human endothelial cells by viable or heat-killed gram-negative bacteria requires soluble CD14.Pathobiology of lipopolysaccharide.Lipopolysaccharide (LPS)-induced cell death of C3H mouse peritoneal macrophages in the presence of cycloheximide: different susceptibilities of C3H/HeN and C3H/HeJ mice macrophages.Safety and pharmacokinetics of an endotoxin-binding phospholipid emulsion.Role for L-selectin in lipopolysaccharide-induced activation of neutrophilsInteraction of hemoglobin with enterobacterial lipopolysaccharide and lipid A. Physicochemical characterization and biological activity.Biophysical characterization of the interaction of high-density lipoprotein (HDL) with endotoxins.Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice.Lipopolysaccharide inhibits virus-mediated induction of interferon genes by disruption of nuclear transport of interferon regulatory factors 3 and 7.Invited review: Bacterial lipopolysaccharides and innate immunity
P2860
Q24310669-B8FEB36F-ADC3-498D-9B98-D61E2E07F5FBQ24514488-11907B5C-E7EC-4D9F-8B31-2B8B196D388EQ26799362-C90288DF-F3FC-4427-BA0A-E2E46F602F6FQ33278833-535A009E-A4F8-48C3-BAB8-0E91E3755942Q33754384-6F61938C-C6C2-4E78-8B18-D630E20690F4Q34005656-3CF8C18D-B235-4245-80ED-A7BB15F484B2Q34017243-00197959-0357-402B-A41D-2A1A6EE72ECBQ34656242-DB73DE89-95F2-420C-BAA9-AAD4FB0BC847Q35123849-49685D2E-B29E-43C6-8739-93C3F5C4A289Q35176262-092955F8-305C-47FD-9506-8FD7D1C4C42FQ35548846-F91F768C-D603-41DC-8357-6DE3955B4809Q35672532-BF11CEEC-299C-4AF2-BE42-0C2124764772Q36364872-92DD8F1B-B2EE-44B3-B642-F85F56D67F70Q36380968-EF78784D-E90C-4E5C-82FA-00C59B077C9EQ37114768-1482B8E8-2579-4F0B-8281-627634795ADAQ37381799-131190C1-CF1F-434D-849B-1852592B699EQ37711304-7912C19C-7CCE-4770-A5C0-C98987A19E8AQ37905144-8C16E1A3-B893-40D3-BCFB-A020847DE695Q38100278-DF783011-A85F-4FAE-ABBC-5214269F4A5BQ38356166-92EBEE07-B863-4CEF-B40B-A11C65F0532DQ39821030-FEC13506-97DE-4BA7-9AD5-909F2AB01D38Q39821110-83B3CF77-C4B0-4EDC-948A-79234971C685Q39823220-FCB88407-0FF3-4D50-91C5-620392C3E6D1Q40646817-ADCF4046-8CFD-4828-A8E1-7B86E894743FQ40844857-BE81DBD5-8095-4F34-8F09-D1E3EA7F61CAQ42166061-57C6B557-A17B-43CC-A817-E0A50BA8FAAAQ42267083-BD58F2E2-8549-4882-9174-FDCCF13D3514Q43698071-1DDB4A4E-CFF4-4C2C-B2A5-C0B292F74AA7Q44224723-C0B1A85F-4E18-4C09-A0B5-6A1C5D3781FAQ44735213-CCF54762-7F77-484F-B1EC-56794343F936Q45749006-C3C2DB4F-A456-4DA3-A26E-CEE10AA1377FQ56610443-5259B03B-96F6-47E0-B03F-3BB05C5CDB57
P2860
Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Lipopolysaccharide-binding pro ...... onsible for endotoxemic shock.
@ast
Lipopolysaccharide-binding pro ...... onsible for endotoxemic shock.
@en
type
label
Lipopolysaccharide-binding pro ...... onsible for endotoxemic shock.
@ast
Lipopolysaccharide-binding pro ...... onsible for endotoxemic shock.
@en
prefLabel
Lipopolysaccharide-binding pro ...... onsible for endotoxemic shock.
@ast
Lipopolysaccharide-binding pro ...... onsible for endotoxemic shock.
@en
P2093
P2860
P356
P1476
Lipopolysaccharide-binding pro ...... onsible for endotoxemic shock.
@en
P2093
P2860
P304
P356
10.1073/PNAS.90.21.9935
P407
P577
1993-11-01T00:00:00Z